UNDUE INFLUENCE 1- INTRODUCTION; 2-WHAT IS UNDUE INFLUENCE Section16 (the Contract Act 1872) CASE LAW ;PLD 1975 SC 624 âTo constitute undue influence there must be either confidence reposed in the person charged or dominating influence with him over the other such to as to render the latter to stand in some respect, in aweâ¦
The first patent for Relpax was originally set to expire in 2013, but this patent was extended to December 2016. This is the earliest possible date that a generic version of Relpax could become available. However, there are other circumstances that could come up to extend the exclusivity period of Relpax beyond 2016.
No -- budesonide and formoterol are the active ingredients in Symbicort (and other medications), but are not generic versions of it. What can be confusing is that, oftentimes, the active ingredient of any drug is referred to as the generic name..The generic name is different from a generic version of a medicine.In order for there to be a generic version of a medicine, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product. Symbicort Drug Information.Advertisement.everal Symbicort patents have already expired. However, no generic versions are yet available. This strongly suggests that one or more later-expiring patents are still protecting the drug from generic competition. The next Symbicort patent is set to expire in December 2012.